- Home
- KROS vs SMBK Comparison
KROS vs SMBK Comparison
Compare KROS & SMBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KROS | SMBK |
|---|---|---|
| Founded | 2015 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 655.9M | 636.5M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | KROS | SMBK |
|---|---|---|
| Price | $18.45 | $36.53 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 4 |
| Target Price | $22.20 | ★ $38.63 |
| AVG Volume (30 Days) | ★ 631.0K | 103.9K |
| Earning Date | 11-05-2025 | 01-20-2026 |
| Dividend Yield | N/A | ★ 0.88% |
| EPS Growth | N/A | ★ 41.99 |
| EPS | 1.57 | ★ 2.74 |
| Revenue | ★ $246,718,000.00 | $188,204,000.00 |
| Revenue This Year | $6,924.79 | $22.00 |
| Revenue Next Year | N/A | $9.67 |
| P/E Ratio | ★ $11.77 | $13.34 |
| Revenue Growth | ★ 37798.31 | 18.22 |
| 52 Week Low | $9.12 | $26.31 |
| 52 Week High | $22.55 | $40.08 |
Technical Indicators
Market Signals| Indicator | KROS | SMBK |
|---|---|---|
| Relative Strength Index (RSI) | 39.45 | 40.32 |
| Support Level | $19.76 | $38.40 |
| Resistance Level | $21.76 | $39.86 |
| Average True Range (ATR) | 0.77 | 0.86 |
| MACD | -0.38 | -0.36 |
| Stochastic Oscillator | 2.47 | 4.82 |
Price Performance
Historical ComparisonAbout KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About SMBK SmartFinancial Inc.
SmartFinancial Inc operates as a bank holding company for SmartBank. It offers various banking and financial services to individuals and corporate customers. The principal business of the Bank consists of attracting deposits from the general public and investing those funds, together with funds generated from operations and from principal and interest payments on loans, mainly in commercial loans, commercial and residential real estate loans, consumer loans, and residential and commercial construction loans. The primary source of revenue is interest income from earning assets, namely loans and securities.